RPG Life Sciences Ltd
RPGLIFE
Company Profile
Business description
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
Contact
463, Dr. Annie Besant Road
RPG House, Near Old Passport Office
Worli
MumbaiMH400030
INDT: +91 2224981650
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
1,738
Stocks News & Analysis
stocks
The fight for Insignia continues
Numerous acquisition proposals vindicate Insignia's improved earnings momentum.
stocks
Trouble continues as Star Entertainment burns through cash
More pain in the horizon as the company struggles to stay afloat.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,656.90 | 27.80 | 0.32% |
| CAC 40 | 7,892.61 | 55.21 | 0.70% |
| DAX 40 | 21,411.53 | 157.26 | 0.74% |
| Dow JONES (US) | 44,565.07 | 408.34 | 0.92% |
| FTSE 100 | 8,565.20 | 20.07 | 0.23% |
| HKSE | 19,700.56 | 78.21 | -0.40% |
| NASDAQ | 20,053.68 | 44.34 | 0.22% |
| Nikkei 225 | 39,958.87 | 312.62 | 0.79% |
| NZX 50 Index | 13,035.67 | 24.41 | -0.19% |
| S&P 500 | 6,118.71 | 32.34 | 0.53% |
| S&P/ASX 200 | 8,406.00 | 27.30 | 0.33% |
| SSE Composite Index | 3,230.16 | 16.54 | 0.51% |